CYP3A and P-glycoprotein activity induction with St. John's Wort in healthy volunteers from 6 ethnic populations.
Xie
Rujia
R
Clinical Pharmacology, Pharmacia.
Tan
Lai Hock
LH
Polasek
Emery C
EC
Hong
Catherine
C
Teillol-Foo
Melvyn
M
Gordi
Toufigh
T
Sharma
Amarnath
A
Nickens
Dana J
DJ
Arakawa
Tomoko
T
Knuth
Dean W
DW
Antal
Edward J
EJ
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000096:biosynthesis* / Q000235:genetics; D000328:Adult; D001741:Black or African American; D044466:Asian People; D051544:Cytochrome P-450 CYP3A / Q000096:biosynthesis*; D005260:Female; D005838:Genotype; D041743:Herb-Drug Interactions / Q000208:ethnology*; D006630:Hispanic or Latino; D006801:Humans; D020902:Hypericum; D008297:Male; D008874:Midazolam / Q000097:blood / Q000493:pharmacokinetics*; D008875:Middle Aged; D010641:Phenotype; D028321:Plant Preparations / Q000494:pharmacology*; D016593:Terfenadine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D044465:White People
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D028321:Plant Preparations; D016593:Terfenadine; C093230:fexofenadine; D051544:Cytochrome P-450 CYP3A; D008874:Midazolam